<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Krystal Biotech, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Krystal Biotech, Inc.

    We are a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. We have a proprietary gene therapy platform, which we refer to as the Skin TARgeted Delivery platform, or STAR-D platform, which we are initially using to develop treatments for rare or orphan dermatological indications. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $96,400,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Krish Krishnan
    • FOUNDED
      2015
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics™ designs, develops, manufactures, and markets proprietary...

    Hypertension Diagnostics™ designs, develops, ma...

    Filing Type:    PU
    Adaptimmune Therapeutics PLC

    Adaptimmune Therapeutics PLC

    Adaptimmune is a leader in TCR T-cell therapy, focused on developing novel cancer ...

    Adaptimmune is a leader in TCR T-cell therapy, ...

    Filing Type:    PU
    Kaleido Biosciences, Inc.

    Kaleido Biosciences, Inc.

    Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, ...

    Kaleido Biosciences is a clinical-stage healthc...

    Filing Type:    PU
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    IntriCon Corporation

    IntriCon Corporation

    For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...

    For more than 40 years, IntriCon has been meeti...

    Filing Type:    PU
    Pacific Biosciences of California, Inc.

    Pacific Biosciences of California, Inc.

    Pacific Biosciences' mission is to transform the way humankind acquires, processes...

    Pacific Biosciences' mission is to transform th...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    REGENXBIO Inc.

    REGENXBIO Inc.

    REGENXBIO is a leading biotechnology company focused on the development, commercia...

    REGENXBIO is a leading biotechnology company fo...

    Filing Type:    PU
    bluebird bio, Inc.

    bluebird bio, Inc.

    bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., h...

    bluebird bio is pioneering gene therapy with pu...

    Filing Type:    PU
    DermTech, Inc.

    DermTech, Inc.

    DermTech is the global leader in molecular dermatology, bringing precision medicin...

    DermTech is the global leader in molecular derm...

    Filing Type:    PU
    Sonoma Pharmaceuticals, Inc.

    Sonoma Pharmaceuticals, Inc.

    Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and mar...

    Sonoma Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Biofrontera AG

    Biofrontera AG

    We have specialized in dermatology, as your skin's health is our concern. We aim t...

    We have specialized in dermatology, as your ski...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.